Genomic Analysis

Explore advanced genomic analysis services to identify cancer-specific mutations, detect chromosomal rearrangements, and develop personalized medicine approaches. Utilizing cutting-edge assays like PCR, NGS, and WES, we provide insights from tumor biopsies, blood samples, FFPE tissues, and more. Empower your research with our detailed genetic profiling solutions.

Applications:
  • Identify and characterize cancer-specific mutations to understand the genetic basis of different cancer types.
  • Detect large chromosomal rearrangements, aiding in the diagnosis and prognosis of cancers.
  • Develop targeted therapies by understanding genetic alterations.
  • Perform comprehensive genomic profiling for personalized medicine approaches.
Samples:
  • Tumor biopsies.
  • Blood samples.
  • FFPE (formalin-fixed, paraffin-embedded) tissue samples.
  • Primary cancer cells and 3D organoids.
Assays:
  • PCR (for known in-dels):
  • Detects specific insertions and deletions within genes.
  • Uses DNA extracted from tumor samples.
  • Sequencing (NGS, WES):
  • NGS (Next-Generation Sequencing) provides high-throughput sequencing to identify a wide range of mutations.
  • WES (Whole Exome Sequencing) focuses on the coding regions of the genome, identifying mutations in protein-coding genes.
Contract research organization, which provides solutions for pharma and diagnostics companies, including consulting, cancer models development, and various assays for drug development.
©2024 DRL US. . All Rights Reserved.
Designed & Developed by Echoru LLC® in California